Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart W Faber

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Plos One|November 18, 2010
Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of responseKwadwo A Kusi, Bart W Faber, Vanessa Riasat, et al.
European Journal of Biochemistry|February 7, 2004
Selective release and function of one of the two FMN groups in the cytoplasmic NAD+-reducing [NiFe]-hydrogenase from Ralstonia eutrophaEddy van der Linden, Bart W Faber, Boris Bleijlevens, et al.
Infection and Immunity|October 17, 2007
Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1Bart W Faber, Edmond J Remarque, William D Morgan, et al.
Malaria Journal|February 16, 2011
Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbitsKwadwo A Kusi, Bart W Faber, Marjolein van der Eijk, et al.
Malaria Journal|July 6, 2011
Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaquesKwadwo A Kusi, Edmond J Remarque, Vanessa Riasat, et al.
Frontiers in Immunology|July 27, 2017
A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis ModelBert A 't Hart, Jordon Dunham, Bart W Faber, et al.
BMC Infectious Diseases|February 4, 2012
Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed populationKwadwo A Kusi, Daniel Dodoo, Samuel Bosomprah, et al.
Infection and Immunity|December 29, 2011
Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite developmentDavid K Moss, Edmond J Remarque, Bart W Faber, et al.
Journal of Structural Biology: X|September 26, 2024
Conformational variability in the D2 loop of <i>Plasmodium</i> Apical Membrane antigen 1Frederick A Saul, Brigitte Vulliez-Le Normand, Alexander Boes, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 2, 2005
Structural differences between the ready and unready oxidized states of [NiFe] hydrogenasesAnne Volbeda, Lydie Martin, Christine Cavazza, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Plos One|November 18, 2010
Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of responseKwadwo A Kusi, Bart W Faber, Vanessa Riasat, et al.
European Journal of Biochemistry|February 7, 2004
Selective release and function of one of the two FMN groups in the cytoplasmic NAD+-reducing [NiFe]-hydrogenase from Ralstonia eutrophaEddy van der Linden, Bart W Faber, Boris Bleijlevens, et al.
Infection and Immunity|October 17, 2007
Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1Bart W Faber, Edmond J Remarque, William D Morgan, et al.
Malaria Journal|February 16, 2011
Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbitsKwadwo A Kusi, Bart W Faber, Marjolein van der Eijk, et al.
Malaria Journal|July 6, 2011
Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaquesKwadwo A Kusi, Edmond J Remarque, Vanessa Riasat, et al.
Frontiers in Immunology|July 27, 2017
A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis ModelBert A 't Hart, Jordon Dunham, Bart W Faber, et al.
BMC Infectious Diseases|February 4, 2012
Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed populationKwadwo A Kusi, Daniel Dodoo, Samuel Bosomprah, et al.
Infection and Immunity|December 29, 2011
Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite developmentDavid K Moss, Edmond J Remarque, Bart W Faber, et al.
Journal of Structural Biology: X|September 26, 2024
Conformational variability in the D2 loop of <i>Plasmodium</i> Apical Membrane antigen 1Frederick A Saul, Brigitte Vulliez-Le Normand, Alexander Boes, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 2, 2005
Structural differences between the ready and unready oxidized states of [NiFe] hydrogenasesAnne Volbeda, Lydie Martin, Christine Cavazza, et al.
Pageof 5